Novel Vaccination Strategies

28.01.2004

Englisch

9783527305230

Wiley-VCH

Nein

628

Gebundene Ausgabe

Prof. Dr. Stefan H.E. Kaufmann, Scientific member of the Max Planck Society, Founding Director of the Max Planck Institute for Infection Biology, Berlin. More than 500 publications and reviews on immunology and infection. Member of numerous scientific societies and committees and winner of prestigious awards. One of the 100 most cited immunologists in the period of 1981 to 1999.

Impfstoff, Virologie, Mikrobiologie, Immunologie

PART I Preface Introduction: Challenges for the vaccine developer, including correlates of protection PART II VACCINATION AND IMMUNE RESPONSE Shaping adaptive immunity against pathogens: the contribution of innate immune responses Adjuvant induced Th2 and Th1 dominated immune responses in vaccination Memory T-cell based vaccines PART III ADJUVANTS Microbial adjuvants Host derived adjuvants Microparticles as vaccine adjuvants and delivery systems Liposomes and ISCOMs Virosomal technology and mucosal adjuvants PART IV CLASSICAL AND NOVEL VACCINATION STRATEGIES: A COMPARISON Classical bacterial vaccines Subunit vaccines and toxoids Engineering virus vectors for subunit vaccines Update on antiviral DNA vaccine research (2000-2003) Live recombinant bacterial vaccines Mucosal vaccination Passive vaccination and antidotes: A novel strategy for generation of wide-spectrum protective antibodies Plant-based oral vaccines Virus-like particles: Combining innate and adaptive immunity for effective vaccination PART V VACCINES FOR SPECIFIC TARGETS Helicobacter pylori Tuberculosis: Novel vaccination strategies against tuberculosis Rationale for malaria vaccine development HIV Vaccines against bioterror agents Part VI VACCINES IN THE REAL WORLD: SAFETY, COST-EFFICIENCY AND IMPACT OF VACCINATION Imperfect vaccines and the evolution of pathogen virulence Cost-effectiveness of vaccinations Immunological safety of vaccines: facts, hypothesis and allegations Index

240 mm

17 cm